AdaptHealth (AHCO) Stock Price, News & Analysis

Company Overview

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Key Stats

• Today's Range: $8.33 to $8.58
• 50-Day Range: $7.33 to $10.84
• 52-Week Range: $7.11 to $11.90
• Volume: 942,001 shs
• Average Volume: 1.28 million shs
• Market Capitalization: $1.16 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $13.60
• Consensus Rating: Buy

AdaptHealth Stock Analysis - MarketRank™

AdaptHealth scored higher than 68% of companies evaluated by MarketBeat, and ranked 297th out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.5 / 5
• Analyst Rating: Buy

Consensus Rating

AdaptHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

AdaptHealth has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 10.23%

Earnings Growth

Earnings for AdaptHealth are expected to grow by 10.23% in the coming year, from $0.88 to $0.97 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of AdaptHealth is -5.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of AdaptHealth is -5.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

AdaptHealth has a PEG Ratio of 1.08. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

AdaptHealth has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.78% of the float of AdaptHealth has been sold short.

Short Interest Ratio / Days to Cover

AdaptHealth has a short interest ratio ("days to cover") of 5.1.

Change versus previous month

Short interest in AdaptHealth has recently increased by 0.59%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AdaptHealth does not currently pay a dividend.

Dividend Growth

AdaptHealth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.78% of the float of AdaptHealth has been sold short.

Short Interest Ratio / Days to Cover

AdaptHealth has a short interest ratio ("days to cover") of 5.1.

Change versus previous month

Short interest in AdaptHealth has recently increased by 0.59%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.17

News Sentiment

AdaptHealth has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 16 news articles for AdaptHealth this week, compared to 4 articles on an average week.

MarketBeat Follows

2 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, AdaptHealth insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.43% of the stock of AdaptHealth is held by insiders.

Percentage Held by Institutions

82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AHCO Stock Analysis - Frequently Asked Questions

How have AHCO shares performed this year?

AdaptHealth's stock was trading at $9.52 at the beginning of 2025. Since then, AHCO shares have decreased by 10.0% and is now trading at $8.57.
View the best growth stocks for 2025 here.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) posted its quarterly earnings data on Tuesday, November, 5th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.02. The business's revenue was up .2% on a year-over-year basis.
Read the conference call transcript.

Who are AdaptHealth's major shareholders?

AdaptHealth's top institutional investors include Vanguard Group Inc. (9.09%), Reinhart Partners LLC. (5.37%), Jefferies Financial Group Inc. and Segall Bryant & Hamill LLC (3.52%). Insiders that own company stock include Everest Hill Group Inc, Skyknight Capital Fund Ii, LP, Skyknight Aero Holdings, Llc, Shaw Rietkerk, Aero Holdings Ii Ll Skyknight, Jason A Clemens, Daniel Bunting, Albert A Prast and David Solomon Williams III.
View institutional ownership trends.

How do I buy shares of AdaptHealth?

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of AdaptHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AdaptHealth investors own include Waste Connections (WCN), AUO (AUOTY), American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 11/05/2024
• Today: 5/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Home health care services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:AHCO
• CIK: 1725255
• Web: www.adapthealth.com
• Phone: (610) 424-4515
• Fax: N/A
• Employees: 10,900
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $13.60
• High Stock Price Target: $16.00
• Low Stock Price Target: $11.00
• Potential Upside/Downside: +58.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.57
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 9.74
• P/E Growth: 1.08
• Net Income: $-678,900,000.00
• Net Margins: -6.57%
• Pretax Margin: -6.33%
• Return on Equity: 9.62%
• Return on Assets: 3.18%

Debt

• Debt-to-Equity Ratio: 1.34
• Current Ratio: 1.24
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: $3.25 billion
• Price / Sales: 0.36
• Cash Flow: $10.58 per share
• Price / Cash Flow: 0.81
• Book Value: $11.06 per share
• Price / Book: 0.77

Miscellaneous

• Outstanding Shares: 134,867,000
• Free Float: 128,594,000
• Market Cap: $1.16 billion
• Optionable: Optionable
• Beta: 1.64